EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors

EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors is a paper indexed in ScholarIQ from OpenAlex.

How many citations does EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors have?

EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors has 1,185 citations in the OpenAlex counts ScholarIQ stores.

When was EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors published?

EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors has 2010 year in the ScholarIQ index.

What is the open-access status of EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors?

EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors has bronze oa status in the ScholarIQ index.

What is the DOI of EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors?

The DOI for EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors is on the source record.

What is the PMID of EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors?

The PMID for EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors is on the source record.

What is the OpenAlex record for EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors?

The OpenAlex for EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors is on the source record.